Global Roxithromycin API Market Growth 2023-2029

February 2023 | 108 pages | ID: G690BE14060BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Roxithromycin(CAS?80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.

LPI (LP Information)' newest research report, the “Roxithromycin API Industry Forecast” looks at past sales and reviews total world Roxithromycin API sales in 2022, providing a comprehensive analysis by region and market sector of projected Roxithromycin API sales for 2023 through 2029. With Roxithromycin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Roxithromycin API industry.

This Insight Report provides a comprehensive analysis of the global Roxithromycin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Roxithromycin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Roxithromycin API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Roxithromycin API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Roxithromycin API.

The global Roxithromycin API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Roxithromycin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Roxithromycin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Roxithromycin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Roxithromycin API players cover Otto Brandes, Beijing Mesochem Technology, Century Pharmaceuticals, Octavius Pharma Pvt. Ltd, HEC Pharm, Kopran, Alembic Pharmaceuticals Limited, Envee Drugs and Zhejiang Zhenyuan Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Roxithromycin API market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Above 98 %
  • Above 99 %
Segmentation by application
  • Tablets
  • Capsules
  • Granules
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Otto Brandes
  • Beijing Mesochem Technology
  • Century Pharmaceuticals
  • Octavius Pharma Pvt. Ltd
  • HEC Pharm
  • Kopran
  • Alembic Pharmaceuticals Limited
  • Envee Drugs
  • Zhejiang Zhenyuan Pharmaceutical
  • Huangshi Shixing Pharmaceutical
  • Hanways Chempharm Co., Limited
Key Questions Addressed in this Report

What is the 10-year outlook for the global Roxithromycin API market?

What factors are driving Roxithromycin API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Roxithromycin API market opportunities vary by end market size?

How does Roxithromycin API break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Roxithromycin API Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Roxithromycin API by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Roxithromycin API by Country/Region, 2018, 2022 & 2029
2.2 Roxithromycin API Segment by Type
  2.2.1 Above 98 %
  2.2.2 Above 99 %
2.3 Roxithromycin API Sales by Type
  2.3.1 Global Roxithromycin API Sales Market Share by Type (2018-2023)
  2.3.2 Global Roxithromycin API Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Roxithromycin API Sale Price by Type (2018-2023)
2.4 Roxithromycin API Segment by Application
  2.4.1 Tablets
  2.4.2 Capsules
  2.4.3 Granules
  2.4.4 Others
2.5 Roxithromycin API Sales by Application
  2.5.1 Global Roxithromycin API Sale Market Share by Application (2018-2023)
  2.5.2 Global Roxithromycin API Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Roxithromycin API Sale Price by Application (2018-2023)

3 GLOBAL ROXITHROMYCIN API BY COMPANY

3.1 Global Roxithromycin API Breakdown Data by Company
  3.1.1 Global Roxithromycin API Annual Sales by Company (2018-2023)
  3.1.2 Global Roxithromycin API Sales Market Share by Company (2018-2023)
3.2 Global Roxithromycin API Annual Revenue by Company (2018-2023)
  3.2.1 Global Roxithromycin API Revenue by Company (2018-2023)
  3.2.2 Global Roxithromycin API Revenue Market Share by Company (2018-2023)
3.3 Global Roxithromycin API Sale Price by Company
3.4 Key Manufacturers Roxithromycin API Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Roxithromycin API Product Location Distribution
  3.4.2 Players Roxithromycin API Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ROXITHROMYCIN API BY GEOGRAPHIC REGION

4.1 World Historic Roxithromycin API Market Size by Geographic Region (2018-2023)
  4.1.1 Global Roxithromycin API Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Roxithromycin API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Roxithromycin API Market Size by Country/Region (2018-2023)
  4.2.1 Global Roxithromycin API Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Roxithromycin API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Roxithromycin API Sales Growth
4.4 APAC Roxithromycin API Sales Growth
4.5 Europe Roxithromycin API Sales Growth
4.6 Middle East & Africa Roxithromycin API Sales Growth

5 AMERICAS

5.1 Americas Roxithromycin API Sales by Country
  5.1.1 Americas Roxithromycin API Sales by Country (2018-2023)
  5.1.2 Americas Roxithromycin API Revenue by Country (2018-2023)
5.2 Americas Roxithromycin API Sales by Type
5.3 Americas Roxithromycin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Roxithromycin API Sales by Region
  6.1.1 APAC Roxithromycin API Sales by Region (2018-2023)
  6.1.2 APAC Roxithromycin API Revenue by Region (2018-2023)
6.2 APAC Roxithromycin API Sales by Type
6.3 APAC Roxithromycin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Roxithromycin API by Country
  7.1.1 Europe Roxithromycin API Sales by Country (2018-2023)
  7.1.2 Europe Roxithromycin API Revenue by Country (2018-2023)
7.2 Europe Roxithromycin API Sales by Type
7.3 Europe Roxithromycin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Roxithromycin API by Country
  8.1.1 Middle East & Africa Roxithromycin API Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Roxithromycin API Revenue by Country (2018-2023)
8.2 Middle East & Africa Roxithromycin API Sales by Type
8.3 Middle East & Africa Roxithromycin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Roxithromycin API
10.3 Manufacturing Process Analysis of Roxithromycin API
10.4 Industry Chain Structure of Roxithromycin API

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Roxithromycin API Distributors
11.3 Roxithromycin API Customer

12 WORLD FORECAST REVIEW FOR ROXITHROMYCIN API BY GEOGRAPHIC REGION

12.1 Global Roxithromycin API Market Size Forecast by Region
  12.1.1 Global Roxithromycin API Forecast by Region (2024-2029)
  12.1.2 Global Roxithromycin API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Roxithromycin API Forecast by Type
12.7 Global Roxithromycin API Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Otto Brandes
  13.1.1 Otto Brandes Company Information
  13.1.2 Otto Brandes Roxithromycin API Product Portfolios and Specifications
  13.1.3 Otto Brandes Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Otto Brandes Main Business Overview
  13.1.5 Otto Brandes Latest Developments
13.2 Beijing Mesochem Technology
  13.2.1 Beijing Mesochem Technology Company Information
  13.2.2 Beijing Mesochem Technology Roxithromycin API Product Portfolios and Specifications
  13.2.3 Beijing Mesochem Technology Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Beijing Mesochem Technology Main Business Overview
  13.2.5 Beijing Mesochem Technology Latest Developments
13.3 Century Pharmaceuticals
  13.3.1 Century Pharmaceuticals Company Information
  13.3.2 Century Pharmaceuticals Roxithromycin API Product Portfolios and Specifications
  13.3.3 Century Pharmaceuticals Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Century Pharmaceuticals Main Business Overview
  13.3.5 Century Pharmaceuticals Latest Developments
13.4 Octavius Pharma Pvt. Ltd
  13.4.1 Octavius Pharma Pvt. Ltd Company Information
  13.4.2 Octavius Pharma Pvt. Ltd Roxithromycin API Product Portfolios and Specifications
  13.4.3 Octavius Pharma Pvt. Ltd Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Octavius Pharma Pvt. Ltd Main Business Overview
  13.4.5 Octavius Pharma Pvt. Ltd Latest Developments
13.5 HEC Pharm
  13.5.1 HEC Pharm Company Information
  13.5.2 HEC Pharm Roxithromycin API Product Portfolios and Specifications
  13.5.3 HEC Pharm Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 HEC Pharm Main Business Overview
  13.5.5 HEC Pharm Latest Developments
13.6 Kopran
  13.6.1 Kopran Company Information
  13.6.2 Kopran Roxithromycin API Product Portfolios and Specifications
  13.6.3 Kopran Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Kopran Main Business Overview
  13.6.5 Kopran Latest Developments
13.7 Alembic Pharmaceuticals Limited
  13.7.1 Alembic Pharmaceuticals Limited Company Information
  13.7.2 Alembic Pharmaceuticals Limited Roxithromycin API Product Portfolios and Specifications
  13.7.3 Alembic Pharmaceuticals Limited Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Alembic Pharmaceuticals Limited Main Business Overview
  13.7.5 Alembic Pharmaceuticals Limited Latest Developments
13.8 Envee Drugs
  13.8.1 Envee Drugs Company Information
  13.8.2 Envee Drugs Roxithromycin API Product Portfolios and Specifications
  13.8.3 Envee Drugs Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Envee Drugs Main Business Overview
  13.8.5 Envee Drugs Latest Developments
13.9 Zhejiang Zhenyuan Pharmaceutical
  13.9.1 Zhejiang Zhenyuan Pharmaceutical Company Information
  13.9.2 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Product Portfolios and Specifications
  13.9.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Zhejiang Zhenyuan Pharmaceutical Main Business Overview
  13.9.5 Zhejiang Zhenyuan Pharmaceutical Latest Developments
13.10 Huangshi Shixing Pharmaceutical
  13.10.1 Huangshi Shixing Pharmaceutical Company Information
  13.10.2 Huangshi Shixing Pharmaceutical Roxithromycin API Product Portfolios and Specifications
  13.10.3 Huangshi Shixing Pharmaceutical Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Huangshi Shixing Pharmaceutical Main Business Overview
  13.10.5 Huangshi Shixing Pharmaceutical Latest Developments
13.11 Hanways Chempharm Co., Limited
  13.11.1 Hanways Chempharm Co., Limited Company Information
  13.11.2 Hanways Chempharm Co., Limited Roxithromycin API Product Portfolios and Specifications
  13.11.3 Hanways Chempharm Co., Limited Roxithromycin API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Hanways Chempharm Co., Limited Main Business Overview
  13.11.5 Hanways Chempharm Co., Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Roxithromycin API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Roxithromycin API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Roxithromycin API Sales by Type (2018-2023) & (Kg)
Table 6. Global Roxithromycin API Sales Market Share by Type (2018-2023)
Table 7. Global Roxithromycin API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Roxithromycin API Revenue Market Share by Type (2018-2023)
Table 9. Global Roxithromycin API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Roxithromycin API Sales by Application (2018-2023) & (Kg)
Table 11. Global Roxithromycin API Sales Market Share by Application (2018-2023)
Table 12. Global Roxithromycin API Revenue by Application (2018-2023)
Table 13. Global Roxithromycin API Revenue Market Share by Application (2018-2023)
Table 14. Global Roxithromycin API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Roxithromycin API Sales by Company (2018-2023) & (Kg)
Table 16. Global Roxithromycin API Sales Market Share by Company (2018-2023)
Table 17. Global Roxithromycin API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Roxithromycin API Revenue Market Share by Company (2018-2023)
Table 19. Global Roxithromycin API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Roxithromycin API Producing Area Distribution and Sales Area
Table 21. Players Roxithromycin API Products Offered
Table 22. Roxithromycin API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Roxithromycin API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Roxithromycin API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Roxithromycin API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Roxithromycin API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Roxithromycin API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Roxithromycin API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Roxithromycin API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Roxithromycin API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Roxithromycin API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Roxithromycin API Sales Market Share by Country (2018-2023)
Table 35. Americas Roxithromycin API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Roxithromycin API Revenue Market Share by Country (2018-2023)
Table 37. Americas Roxithromycin API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Roxithromycin API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Roxithromycin API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Roxithromycin API Sales Market Share by Region (2018-2023)
Table 41. APAC Roxithromycin API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Roxithromycin API Revenue Market Share by Region (2018-2023)
Table 43. APAC Roxithromycin API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Roxithromycin API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Roxithromycin API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Roxithromycin API Sales Market Share by Country (2018-2023)
Table 47. Europe Roxithromycin API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Roxithromycin API Revenue Market Share by Country (2018-2023)
Table 49. Europe Roxithromycin API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Roxithromycin API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Roxithromycin API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Roxithromycin API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Roxithromycin API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Roxithromycin API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Roxithromycin API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Roxithromycin API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Roxithromycin API
Table 58. Key Market Challenges & Risks of Roxithromycin API
Table 59. Key Industry Trends of Roxithromycin API
Table 60. Roxithromycin API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Roxithromycin API Distributors List
Table 63. Roxithromycin API Customer List
Table 64. Global Roxithromycin API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Roxithromycin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Roxithromycin API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Roxithromycin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Roxithromycin API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Roxithromycin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Roxithromycin API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Roxithromycin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Roxithromycin API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Roxithromycin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Roxithromycin API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Roxithromycin API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Roxithromycin API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Roxithromycin API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Otto Brandes Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 79. Otto Brandes Roxithromycin API Product Portfolios and Specifications
Table 80. Otto Brandes Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Otto Brandes Main Business
Table 82. Otto Brandes Latest Developments
Table 83. Beijing Mesochem Technology Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 84. Beijing Mesochem Technology Roxithromycin API Product Portfolios and Specifications
Table 85. Beijing Mesochem Technology Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Beijing Mesochem Technology Main Business
Table 87. Beijing Mesochem Technology Latest Developments
Table 88. Century Pharmaceuticals Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 89. Century Pharmaceuticals Roxithromycin API Product Portfolios and Specifications
Table 90. Century Pharmaceuticals Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Century Pharmaceuticals Main Business
Table 92. Century Pharmaceuticals Latest Developments
Table 93. Octavius Pharma Pvt. Ltd Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 94. Octavius Pharma Pvt. Ltd Roxithromycin API Product Portfolios and Specifications
Table 95. Octavius Pharma Pvt. Ltd Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Octavius Pharma Pvt. Ltd Main Business
Table 97. Octavius Pharma Pvt. Ltd Latest Developments
Table 98. HEC Pharm Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 99. HEC Pharm Roxithromycin API Product Portfolios and Specifications
Table 100. HEC Pharm Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. HEC Pharm Main Business
Table 102. HEC Pharm Latest Developments
Table 103. Kopran Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 104. Kopran Roxithromycin API Product Portfolios and Specifications
Table 105. Kopran Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Kopran Main Business
Table 107. Kopran Latest Developments
Table 108. Alembic Pharmaceuticals Limited Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 109. Alembic Pharmaceuticals Limited Roxithromycin API Product Portfolios and Specifications
Table 110. Alembic Pharmaceuticals Limited Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Alembic Pharmaceuticals Limited Main Business
Table 112. Alembic Pharmaceuticals Limited Latest Developments
Table 113. Envee Drugs Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 114. Envee Drugs Roxithromycin API Product Portfolios and Specifications
Table 115. Envee Drugs Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Envee Drugs Main Business
Table 117. Envee Drugs Latest Developments
Table 118. Zhejiang Zhenyuan Pharmaceutical Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Product Portfolios and Specifications
Table 120. Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Zhejiang Zhenyuan Pharmaceutical Main Business
Table 122. Zhejiang Zhenyuan Pharmaceutical Latest Developments
Table 123. Huangshi Shixing Pharmaceutical Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 124. Huangshi Shixing Pharmaceutical Roxithromycin API Product Portfolios and Specifications
Table 125. Huangshi Shixing Pharmaceutical Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Huangshi Shixing Pharmaceutical Main Business
Table 127. Huangshi Shixing Pharmaceutical Latest Developments
Table 128. Hanways Chempharm Co., Limited Basic Information, Roxithromycin API Manufacturing Base, Sales Area and Its Competitors
Table 129. Hanways Chempharm Co., Limited Roxithromycin API Product Portfolios and Specifications
Table 130. Hanways Chempharm Co., Limited Roxithromycin API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. Hanways Chempharm Co., Limited Main Business
Table 132. Hanways Chempharm Co., Limited Latest Developments

LIST OF FIGURES

Figure 1. Picture of Roxithromycin API
Figure 2. Roxithromycin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Roxithromycin API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Roxithromycin API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Roxithromycin API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Roxithromycin API Sales Market Share by Type in 2022
Figure 12. Global Roxithromycin API Revenue Market Share by Type (2018-2023)
Figure 13. Roxithromycin API Consumed in Tablets
Figure 14. Global Roxithromycin API Market: Tablets (2018-2023) & (Kg)
Figure 15. Roxithromycin API Consumed in Capsules
Figure 16. Global Roxithromycin API Market: Capsules (2018-2023) & (Kg)
Figure 17. Roxithromycin API Consumed in Granules
Figure 18. Global Roxithromycin API Market: Granules (2018-2023) & (Kg)
Figure 19. Roxithromycin API Consumed in Others
Figure 20. Global Roxithromycin API Market: Others (2018-2023) & (Kg)
Figure 21. Global Roxithromycin API Sales Market Share by Application (2022)
Figure 22. Global Roxithromycin API Revenue Market Share by Application in 2022
Figure 23. Roxithromycin API Sales Market by Company in 2022 (Kg)
Figure 24. Global Roxithromycin API Sales Market Share by Company in 2022
Figure 25. Roxithromycin API Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Roxithromycin API Revenue Market Share by Company in 2022
Figure 27. Global Roxithromycin API Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Roxithromycin API Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Roxithromycin API Sales 2018-2023 (Kg)
Figure 30. Americas Roxithromycin API Revenue 2018-2023 ($ Millions)
Figure 31. APAC Roxithromycin API Sales 2018-2023 (Kg)
Figure 32. APAC Roxithromycin API Revenue 2018-2023 ($ Millions)
Figure 33. Europe Roxithromycin API Sales 2018-2023 (Kg)
Figure 34. Europe Roxithromycin API Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Roxithromycin API Sales 2018-2023 (Kg)
Figure 36. Middle East & Africa Roxithromycin API Revenue 2018-2023 ($ Millions)
Figure 37. Americas Roxithromycin API Sales Market Share by Country in 2022
Figure 38. Americas Roxithromycin API Revenue Market Share by Country in 2022
Figure 39. Americas Roxithromycin API Sales Market Share by Type (2018-2023)
Figure 40. Americas Roxithromycin API Sales Market Share by Application (2018-2023)
Figure 41. United States Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Roxithromycin API Sales Market Share by Region in 2022
Figure 46. APAC Roxithromycin API Revenue Market Share by Regions in 2022
Figure 47. APAC Roxithromycin API Sales Market Share by Type (2018-2023)
Figure 48. APAC Roxithromycin API Sales Market Share by Application (2018-2023)
Figure 49. China Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Roxithromycin API Sales Market Share by Country in 2022
Figure 57. Europe Roxithromycin API Revenue Market Share by Country in 2022
Figure 58. Europe Roxithromycin API Sales Market Share by Type (2018-2023)
Figure 59. Europe Roxithromycin API Sales Market Share by Application (2018-2023)
Figure 60. Germany Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Roxithromycin API Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Roxithromycin API Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Roxithromycin API Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Roxithromycin API Sales Market Share by Application (2018-2023)
Figure 69. Egypt Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Roxithromycin API Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Roxithromycin API in 2022
Figure 75. Manufacturing Process Analysis of Roxithromycin API
Figure 76. Industry Chain Structure of Roxithromycin API
Figure 77. Channels of Distribution
Figure 78. Global Roxithromycin API Sales Market Forecast by Region (2024-2029)
Figure 79. Global Roxithromycin API Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Roxithromycin API Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Roxithromycin API Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Roxithromycin API Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Roxithromycin API Revenue Market Share Forecast by Application (2024-2029)


More Publications